Polysomnography Utilization in Veterans Presenting Acutely with Ischemic Stroke or Transient Ischemic Attack

Brian B. Koo, Jason J. Sico, Laura J. Myers, Anthony J. Perkins, Deborah Levine, Edward J. Miech, Teresa M. Damush, Nicholas Rattray, Barbara Homoya, Jared Ferguson, Jennifer Myers, Ying Zhang, Dawn M. Bravata

Research output: Contribution to journalArticle

Abstract

Introduction: Obstructive sleep apnea (OSA) is an independent cerebrovascular risk factor and highly prevalent in patients with ischemic stroke and transient ischemic attack (TIA). Timely diagnosis and treatment of OSA is important as clinical data suggest that treatment of OSA in the setting of acute ischemic stroke improves functional outcomes. We aimed to assess polysomnography (PSG) utilization in US. Veterans with acute stroke or TIA over a 2-year period. Methods: Veterans with acute ischemic stroke or TIA presenting to a Veterans Administration Medical Center (VAMC) between October 1, 2015, and June 30, 2017, were included. Demographic, clinical data, and PSG within 12 months of hospital discharge were obtained from the VA Corporate Data Warehouse to determine the rate of PSG testing among those with acute ischemic stroke or TIA. Fisher's exact test and two-sample t tests were used to compare demographic and clinical characteristics for those receiving and not receiving PSG. Mixed effect logistic regression was used to model the association of clinical and demographic characteristics with PSG receipt. Results: In fiscal years (FYs) 2016 and 2017, 9,200 Veterans were admitted to a VAMC with ischemic stroke (6,011) or TIA (3,089). Veterans were elderly (70.5 ± 11.1 years), predominantly male (95.7%), and largely Caucasian (68.0% Caucasian, 26.3% African-American). Just 6.0% of Veterans underwent PSG within 1 year of acute ischemic stroke or TIA in FY 2016, compared to 6.2% in FY 2017 (p = 0.72). Compared to Veterans ≥80 years, those <60 had adjusted OR of 6.73 (4.10-11.05), those 60-69 had OR 4.29 (2.73-6.74), and those 70-79 had OR 2.63 (1.66-4.18) of having PSG. Veterans with diabetes or heart failure had significantly higher odds, whereas those with dementia had significantly lower odds of receiving PSG. Conclusion: PSG utilization among US Veterans is low and stable over time, despite recent guidelines recommending PSG among those having stroke or TIA. Older Veterans and those with dementia were unlikely to get PSG, representing especially vulnerable populations.

Original languageEnglish (US)
JournalCerebrovascular Diseases
DOIs
StateAccepted/In press - Jan 1 2019
Externally publishedYes

Fingerprint

Polysomnography
Transient Ischemic Attack
Veterans
Stroke
Obstructive Sleep Apnea
United States Department of Veterans Affairs
Demography
Dementia
Vulnerable Populations
African Americans
Heart Failure
Logistic Models
Guidelines

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Polysomnography Utilization in Veterans Presenting Acutely with Ischemic Stroke or Transient Ischemic Attack. / Koo, Brian B.; Sico, Jason J.; Myers, Laura J.; Perkins, Anthony J.; Levine, Deborah; Miech, Edward J.; Damush, Teresa M.; Rattray, Nicholas; Homoya, Barbara; Ferguson, Jared; Myers, Jennifer; Zhang, Ying; Bravata, Dawn M.

In: Cerebrovascular Diseases, 01.01.2019.

Research output: Contribution to journalArticle

Koo, Brian B. ; Sico, Jason J. ; Myers, Laura J. ; Perkins, Anthony J. ; Levine, Deborah ; Miech, Edward J. ; Damush, Teresa M. ; Rattray, Nicholas ; Homoya, Barbara ; Ferguson, Jared ; Myers, Jennifer ; Zhang, Ying ; Bravata, Dawn M. / Polysomnography Utilization in Veterans Presenting Acutely with Ischemic Stroke or Transient Ischemic Attack. In: Cerebrovascular Diseases. 2019.
@article{3e51ec73e9e74afd99f3e2e46ae142a0,
title = "Polysomnography Utilization in Veterans Presenting Acutely with Ischemic Stroke or Transient Ischemic Attack",
abstract = "Introduction: Obstructive sleep apnea (OSA) is an independent cerebrovascular risk factor and highly prevalent in patients with ischemic stroke and transient ischemic attack (TIA). Timely diagnosis and treatment of OSA is important as clinical data suggest that treatment of OSA in the setting of acute ischemic stroke improves functional outcomes. We aimed to assess polysomnography (PSG) utilization in US. Veterans with acute stroke or TIA over a 2-year period. Methods: Veterans with acute ischemic stroke or TIA presenting to a Veterans Administration Medical Center (VAMC) between October 1, 2015, and June 30, 2017, were included. Demographic, clinical data, and PSG within 12 months of hospital discharge were obtained from the VA Corporate Data Warehouse to determine the rate of PSG testing among those with acute ischemic stroke or TIA. Fisher's exact test and two-sample t tests were used to compare demographic and clinical characteristics for those receiving and not receiving PSG. Mixed effect logistic regression was used to model the association of clinical and demographic characteristics with PSG receipt. Results: In fiscal years (FYs) 2016 and 2017, 9,200 Veterans were admitted to a VAMC with ischemic stroke (6,011) or TIA (3,089). Veterans were elderly (70.5 ± 11.1 years), predominantly male (95.7{\%}), and largely Caucasian (68.0{\%} Caucasian, 26.3{\%} African-American). Just 6.0{\%} of Veterans underwent PSG within 1 year of acute ischemic stroke or TIA in FY 2016, compared to 6.2{\%} in FY 2017 (p = 0.72). Compared to Veterans ≥80 years, those <60 had adjusted OR of 6.73 (4.10-11.05), those 60-69 had OR 4.29 (2.73-6.74), and those 70-79 had OR 2.63 (1.66-4.18) of having PSG. Veterans with diabetes or heart failure had significantly higher odds, whereas those with dementia had significantly lower odds of receiving PSG. Conclusion: PSG utilization among US Veterans is low and stable over time, despite recent guidelines recommending PSG among those having stroke or TIA. Older Veterans and those with dementia were unlikely to get PSG, representing especially vulnerable populations.",
author = "Koo, {Brian B.} and Sico, {Jason J.} and Myers, {Laura J.} and Perkins, {Anthony J.} and Deborah Levine and Miech, {Edward J.} and Damush, {Teresa M.} and Nicholas Rattray and Barbara Homoya and Jared Ferguson and Jennifer Myers and Ying Zhang and Bravata, {Dawn M.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1159/000504406",
language = "English (US)",
journal = "Cerebrovascular Diseases",
issn = "1015-9770",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Polysomnography Utilization in Veterans Presenting Acutely with Ischemic Stroke or Transient Ischemic Attack

AU - Koo, Brian B.

AU - Sico, Jason J.

AU - Myers, Laura J.

AU - Perkins, Anthony J.

AU - Levine, Deborah

AU - Miech, Edward J.

AU - Damush, Teresa M.

AU - Rattray, Nicholas

AU - Homoya, Barbara

AU - Ferguson, Jared

AU - Myers, Jennifer

AU - Zhang, Ying

AU - Bravata, Dawn M.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: Obstructive sleep apnea (OSA) is an independent cerebrovascular risk factor and highly prevalent in patients with ischemic stroke and transient ischemic attack (TIA). Timely diagnosis and treatment of OSA is important as clinical data suggest that treatment of OSA in the setting of acute ischemic stroke improves functional outcomes. We aimed to assess polysomnography (PSG) utilization in US. Veterans with acute stroke or TIA over a 2-year period. Methods: Veterans with acute ischemic stroke or TIA presenting to a Veterans Administration Medical Center (VAMC) between October 1, 2015, and June 30, 2017, were included. Demographic, clinical data, and PSG within 12 months of hospital discharge were obtained from the VA Corporate Data Warehouse to determine the rate of PSG testing among those with acute ischemic stroke or TIA. Fisher's exact test and two-sample t tests were used to compare demographic and clinical characteristics for those receiving and not receiving PSG. Mixed effect logistic regression was used to model the association of clinical and demographic characteristics with PSG receipt. Results: In fiscal years (FYs) 2016 and 2017, 9,200 Veterans were admitted to a VAMC with ischemic stroke (6,011) or TIA (3,089). Veterans were elderly (70.5 ± 11.1 years), predominantly male (95.7%), and largely Caucasian (68.0% Caucasian, 26.3% African-American). Just 6.0% of Veterans underwent PSG within 1 year of acute ischemic stroke or TIA in FY 2016, compared to 6.2% in FY 2017 (p = 0.72). Compared to Veterans ≥80 years, those <60 had adjusted OR of 6.73 (4.10-11.05), those 60-69 had OR 4.29 (2.73-6.74), and those 70-79 had OR 2.63 (1.66-4.18) of having PSG. Veterans with diabetes or heart failure had significantly higher odds, whereas those with dementia had significantly lower odds of receiving PSG. Conclusion: PSG utilization among US Veterans is low and stable over time, despite recent guidelines recommending PSG among those having stroke or TIA. Older Veterans and those with dementia were unlikely to get PSG, representing especially vulnerable populations.

AB - Introduction: Obstructive sleep apnea (OSA) is an independent cerebrovascular risk factor and highly prevalent in patients with ischemic stroke and transient ischemic attack (TIA). Timely diagnosis and treatment of OSA is important as clinical data suggest that treatment of OSA in the setting of acute ischemic stroke improves functional outcomes. We aimed to assess polysomnography (PSG) utilization in US. Veterans with acute stroke or TIA over a 2-year period. Methods: Veterans with acute ischemic stroke or TIA presenting to a Veterans Administration Medical Center (VAMC) between October 1, 2015, and June 30, 2017, were included. Demographic, clinical data, and PSG within 12 months of hospital discharge were obtained from the VA Corporate Data Warehouse to determine the rate of PSG testing among those with acute ischemic stroke or TIA. Fisher's exact test and two-sample t tests were used to compare demographic and clinical characteristics for those receiving and not receiving PSG. Mixed effect logistic regression was used to model the association of clinical and demographic characteristics with PSG receipt. Results: In fiscal years (FYs) 2016 and 2017, 9,200 Veterans were admitted to a VAMC with ischemic stroke (6,011) or TIA (3,089). Veterans were elderly (70.5 ± 11.1 years), predominantly male (95.7%), and largely Caucasian (68.0% Caucasian, 26.3% African-American). Just 6.0% of Veterans underwent PSG within 1 year of acute ischemic stroke or TIA in FY 2016, compared to 6.2% in FY 2017 (p = 0.72). Compared to Veterans ≥80 years, those <60 had adjusted OR of 6.73 (4.10-11.05), those 60-69 had OR 4.29 (2.73-6.74), and those 70-79 had OR 2.63 (1.66-4.18) of having PSG. Veterans with diabetes or heart failure had significantly higher odds, whereas those with dementia had significantly lower odds of receiving PSG. Conclusion: PSG utilization among US Veterans is low and stable over time, despite recent guidelines recommending PSG among those having stroke or TIA. Older Veterans and those with dementia were unlikely to get PSG, representing especially vulnerable populations.

UR - http://www.scopus.com/inward/record.url?scp=85075182164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075182164&partnerID=8YFLogxK

U2 - 10.1159/000504406

DO - 10.1159/000504406

M3 - Article

C2 - 31722335

AN - SCOPUS:85075182164

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

SN - 1015-9770

ER -